cgp 35348 has been researched along with 1-hydroxy-3-amino-2-pyrrolidone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldmeier, PC | 1 |
| Connelly, ST; Grobaski, KC; Lehmann, H; Shepard, PD | 1 |
| Bowery, NG; Connelly, ST; daSilva, HM; Grobaski, KC; Ping, H; Shepard, PD | 1 |
3 other study(ies) available for cgp 35348 and 1-hydroxy-3-amino-2-pyrrolidone
| Article | Year |
|---|---|
The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.
Topics: 4-Butyrolactone; Animals; Baclofen; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; GABA-A Receptor Antagonists; Haloperidol; Organophosphorus Compounds; Pyrrolidinones; Rats; Tetrabenazine | 1991 |
Effects of the enantiomers of (+/-)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule.
Topics: Animals; Dose-Response Relationship, Drug; Male; Organophosphorus Compounds; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate; Stereoisomerism; Substantia Nigra | 1995 |
Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro.
Topics: Animals; Baclofen; Dopamine; Electrophysiology; Excitatory Amino Acid Agonists; GABA Agonists; Male; Neurons; Organophosphorus Compounds; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Substantia Nigra | 1997 |